•  
  •  
Caveat Emptor: Reverse Mergers – Reverse Takeovers (RTO)

Caveat Emptor: Reverse Mergers – Reverse Takeovers (RTO)

I have invested in a few private companies over the years that later went public by way of reverse merging into a shell ie: Reverse Takeover (RTO).  For this article I will use “reverse merger” and “RTO” interchangeably.

Reverse Takeover Defined: A type of merger used by private companies to become publicly traded without resorting to an initial public offering. Initially, the private company buys enough shares to control a publicly traded company. The private company’s shareholder then uses their shares in the private company to exchange for shares in the public company. At this point, the private company has effectively become a publicly traded one.

What I’ve learned is new investors need to be careful when buying a company that has recently completed an RTO.  I’m not referring to fraud or anything of that nature although plenty of fraudulent private companies do use RTO’s as a way to cheaply go public and raise capital from unsuspecting investors (just Google “Chinese RTO”).

In most cases when a private company reverse merges into a shell company (RTO) investors in the successor’s stock are restricted until a registration statement becomes effective or at the latest after 12 months.  The only stock that is available to trade (or be sold) is stock being held by the shells original shareholders (a very small amount).

So often times, right after an RTO is complete you will see a stock creep its way higher on very little volume.  Why? Because no one can really sell their stock.  It’s just the old laws of supply and demand and in this case there is no supply.  Then when a registration statement becomes effective and/or after the one-year anniversary date of the RTO, a huge amount of supply hits (investors are able to sell) the market and the stock plummets.

Click Here

This happens all the time.  An example is Bacterin (BONE) which reverse merged into a shell on 07/2010, and in early 2011 the registration statement went effective unlocking several million shares.  As you can see in the chart, the stock starts to drop. Then after the one-year anniversary of the merger on 07/2011, another several million shares became unlocked.  It can take several weeks to several months sometimes to absorb the amount of shares that become unlocked, which obviously pushes down the stock price.

Particularly, if you are a micro cap investor, it’s important to understand the dynamics of a reverse merger/RTO, and be very cautious buying a stock that is still within the one-year anniversary from the reverse merger date.

The MicroCapClub (mc2) is an exclusive micro cap forum focused on micro cap companies (sub $500m market cap). The MicroCapClub was created and founded by Ian Cassel as a way to share ideas and to learn from other seasoned like-minded micro cap investors. Our goal at MicroCapClub.com is quality membership and quality stock ideas.  If you are an experienced micro cap investor, feel free to Apply today.

About Ian Cassel

Founder of MicroCapClub, Ian is a full time private investor focusing on micro cap companies. He lost a lot of money early on in his investing career in micro caps, which motivated him to learn from losing. Now he loses less. Ian created MicroCapClub as a place for experienced micro cap investors to share and discuss ideas.

One thought on “Caveat Emptor: Reverse Mergers – Reverse Takeovers (RTO)

  1. Nice article Ian.

    I full subscribe to the “caveat emptor” on Reverse Mergers.
    Although a legitimate financial tool, and in many cases create wealth, I feel that it ultimately, it comes down to the “backers” in an R/M purchase.
    I really liked BONE, especially before they hit NYSE, I thought they showed a lot promise and at the time their technology and products were unique.
    In fact, I STILL like the company’s product, but the management has scared me for the past few years with their handling of the company; continually “dipping into the well,” failure to execute and such.
    I am wondering when their R&D (cap ex) from 2010 will show fruition. It seems that i am hearing about other cartilage and bone companies since about a year ago now… who will be the preferred technology? And for that matter, the cap ex on R&D this year seems fairly low.
    I don’t own now, and probably won’t purchase until I see some significant developments on this one.
    Any specific replies to these questions would be very welcome.

    Sincerely

    Scott

Leave a Reply

Your email address will not be published. Required fields are marked *

*